ReviewJournal of the International AIDS Society2011
Epistemic fault lines in biomedical and social approaches to HIV prevention.
Review in Journal of the International AIDS Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Efficacy of a culturally congruent HIV risk-reduction intervention for behaviorally bisexual black men: results of a randomized trial.AIDS (London, England) · 2013Trial
- Theorizing causality: A qualitative study of xylazine-related wound diversity and perceived etiology among people who inject drugs.Addiction (Abingdon, England) · 2026Article
- Responsible innovation in multi-organ-on-a-chip research: A qualitative study of biomedical scientists' views on the value and development of models for obesity.NAM journal · 2026Article
- Styles of thought in healthcare governance: A situational analysis of English PrEP discourse 2016-2020.BioSocieties · 2025Article
- Spatializing HIV: Putting Queer (men) in its place via social marketing.Dialogues in health · 2024Article
- "Syndemic moral distress": sexual health provider practices in the context of co-occurring, socially produced sexual and mental health epidemics.BMC health services research · 2022Article
- Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation.Social theory & health : STH · 2022Article
- Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.Journal of the International AIDS Society · 2018Article
- Criminalization of HIV non-disclosure: Narratives from young men living in Vancouver, Canada.PloS one · 2018Article
- 'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.Addiction (Abingdon, England) · 2017Article
- Expanding the knowledge translation metaphor.Health research policy and systems · 2017Article
- Article
- Prevention literacy: community-based advocacy for access and ownership of the HIV prevention toolkit.Journal of the International AIDS Society · 2016Review
- Uptake of Community-Based Peer Administered HIV Point-of-Care Testing: Findings from the PROUD Study.PloS one · 2016Article
- Pharmaceutical HIV prevention technologies in the UK: six domains for social science research.AIDS care · 2015Review
- Investigating combination HIV prevention: isolated interventions or complex system.Journal of the International AIDS Society · 2015Article
- Expanding the prevention armamentarium portfolio: a framework for promoting HIV-Conversant Communities within a complex, adaptive epidemiological landscape.SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance · 2015Article
- An open debate about the object and purpose of global health knowledge in the context of an interdisciplinary research partnership on HIV/STI prevention priorities in Peru.Globalization and health · 2014Article
- Structural approaches for prevention of sexually transmitted HIV in general populations: definitions and an operational approach.Journal of the International AIDS Society · 2014Review
- Between individual agency and structure in HIV prevention: understanding the middle ground of social practice.American journal of public health · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper raises the question of how knowledge creation is organized in the area of HIV prevention and how this concatenation of expertise, resources, at-risk people and viruses shapes the knowledge used to impede the epidemic. It also seeks to trouble the discourses of biomedical pre-eminence in the field of HIV prevention by examining the claim for treatment as prevention, looking at evidence constructed through the biomedical frame and through the lens of the sociology of science. These questions lie within a larger socio-historical context of lagging worldwide attention and funding to prevention in the HIV area and, in particular, neglect of populations at greatest risk. Much contemporary HIV prevention research relies on a population science divided over an epistemic fault line from the communities and individuals who must make sense of the intrusion of a life-threatening disease into their pursuit of pleasure and intimacy. There are, nevertheless, lessons to be learned from prevention success stories among sex workers, injection drug users, and gay and bisexual men. The success stories point to a need for a robust social science agenda that examines: the ways that people are socially organized and networked; the popular strategies and folk wisdoms developed in the face of HIV risk; socio-historical movement of sexual and drug cultures; the dynamics of popular mobilization to advance health; the institutional sources of HIV discourses; and popular understandings of HIV technologies and messages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.